SCHEMBL1035129

SCHEMBL1035129

CC(C)Cc1c(CO)sc2cc(C(F)(F)F)ccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 1/20 0.35
PTGER3 P43115 1/20 0.35
PDE2A O00408 3/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
DYRK1A Q13627 2/20 0.33
EPHX2 P34913 1/20 0.33
SCN4A P35499 1/20 0.33
CSNK1D P48730 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
KIF11 P52732 1/20 0.31
NPY1R P25929 1/20 0.31
PPARA Q07869 1/20 0.31
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27829371 0.85 AKR1B1 (0.41) PTGER1PTGER3CSNK1DPPARA
SCHEMBL4654027 0.85 MEN1 (0.39) PDE2ADYRK1AEPHX2SCN4ACSNK1D
SCHEMBL1033037 0.82 NPY1R (0.36) PDE2ADYRK1AEPHX2SCN4ACSNK1D
SCHEMBL1031874 0.81 KIF11 (0.36) PDE2AHTR2AHTR2CHTR2BDYRK1A
SCHEMBL1033672 0.80 NPY1R (0.35) PDE2ADYRK1AEPHX2SCN4ACSNK1D
SCHEMBL1075156 0.79 MEN1 (0.39) DYRK1AEPHX2SCN4ACSNK1DHRH4
SCHEMBL27808932 0.78 HRH4 (0.34) PTGER1PTGER3PDE2AHTR2AHTR2C
SCHEMBL1030697 0.77 PTGER1 (0.34) PTGER1PTGER3PDE2AHTR2AHTR2C
SCHEMBL1030581 0.76 ALDH1A1 (0.43) PTGER1PTGER3DYRK1ACSNK1D
SCHEMBL27829370 0.76 ALDH1A1 (0.40) PTGER1PTGER3DYRK1ACSNK1DKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD PTGER1 144/4885PTGER3 521/4885PDE2A 1843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.